N 4 -aryl substituted thiosemicarbazones derived from 1-indanones as potential anti-tumor agents for breast cancer treatment

Aldana Sólimo, Maria Cristina Soraires Santacruz, Andrea I. Loaiza Perez, Elisa Bal de Kier Joffé, Liliana M. Finkielsztein, Mariana A. Callero
  • Journal of Cellular Physiology, January 2018, Wiley
  • DOI: 10.1002/jcp.26240
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: